April 16, 2018
Since its inception 17 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including the hypereosinophilic syndromes and mastocytosis.
This year’s CME-accredited program will feature the latest evidence on the pathophysiology and management of these disorders through lectures, interactive question-and-answer sessions and a peer-reviewed scientific abstract session.
New features this year include a discussion of myeloproliferative neoplasms in childhood and adolescence, a series of debates between experts on controversial management issues such as when to initiate interferon therapy, the role of cytoreduction in essential thrombocytosis and the use of ruxolitinib relative to hydroxyurea.
We hope you will join us for what has become the premier forum for discussion on the latest advances in the myeloproliferative neoplasms!
For more information, contact the Meeting Organizer:
Melton Medical Education, LLC
Phone: 512-619-5534
Email: heather@meltonmeded.com
Location:
InterContinental New York Times Square in New York, New York
300 W 44th St, New York, NY 10036